Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Reviva Pharmaceuticals Holdings ( (RVPH) ) just unveiled an announcement.
On October 14, 2025, Reviva Pharmaceuticals Holdings, Inc. announced it regained compliance with Nasdaq’s minimum Market Value of Listed Securities requirement, resolving a previous non-compliance issue. However, the company remains non-compliant with the Nasdaq’s minimum bid price requirement and has until November 10, 2025, to address this, considering options like a reverse stock split to meet the criteria.
The most recent analyst rating on (RVPH) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Reviva Pharmaceuticals Holdings stock, see the RVPH Stock Forecast page.
Spark’s Take on RVPH Stock
According to Spark,…
